Generate Biomedicines, Inc. (GENB)
17.17
+0.05
(+0.29%)
USD |
NASDAQ |
Sep 18, 16:00
17.17
0.00 (0.00%)
After-Hours: 20:00
Generate Biomedicines Free Cash Flow : -245.88M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -245.88M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Twist Bioscience Corp. | -93.22M |
| Intellia Therapeutics, Inc. | -348.69M |
| Prime Medicine, Inc. | -156.85M |
| Moderna, Inc. | -1.244B |
| Beam Therapeutics, Inc. | -372.77M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -57.94M |
| Cash from Investing (Quarterly) | 33.31M |
| Cash from Financing (Quarterly) | -0.579M |
| Free Cash Flow Per Share (Quarterly) | -0.459 |
| Free Cash Flow to Equity (Quarterly) | -55.94M |
| Free Cash Flow to Firm (Quarterly) | -58.72M |
| Free Cash Flow Yield | -17.76% |